| |
|
|
|
Lipocine Inc.
|
|
3.59 -0.12 (-3.23%) |
10/23/2017 3:59pm |
|
Open: |
3.73 |
Pre close: |
3.71 |
Target:
|
4.74 
|
|
High: |
3.80 |
Low: |
3.55 |
Resistance:
|
4.06
4.38
|
|
Volume: |
375,498 |
Market Cap: |
73.89M |
Support:
|
3.55
2.95
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.77
|
MACD |
MACD(12,26):
|
-0.08 |
|
MA(20): |
3.96 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
4.13 |
Stochastic Oscillator |
%K(14,3):
|
12.23 |
|
MA(250): |
3.89  |
%D(3): |
21.22 |
|
Average Volume(K) |
3-Month: |
18696
|
52-Week |
High:
|
5.33 |
|
10-Days: |
25875 |
Low: |
3.03 |
|
RSI |
RSI(14):
|
38.46 |
Change(%): |
5.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.930 |
Return on Equity (ttm) |
-61.4 |
Shares Out. (M) |
20.00 |
|
EPS Est. Current Year |
-0.960 |
Return on Assets (ttm) |
-33.8 |
Shares Float (M) |
19.40 |
|
EPS Est. Next Year |
-0.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.87 |
|
EPS Est. Next Quarter |
-0.190 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
26.69 |
|
Forward EPS |
-0.721 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1810 |
|
Book Value (p.s.) |
1.220 |
EBITDA (p.s.) |
-0.830 |
P/E |
-3.86 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.94 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.44 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-7.71 |
P/CF |
-4.97 |
|
|
|
|
|
|
|
